Back to top

Image: Bigstock

Alignment Healthcare (ALHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

For the quarter ended March 2026, Alignment Healthcare (ALHC - Free Report) reported revenue of $1.24 billion, up 33.3% over the same period last year. EPS came in at $0.05, compared to -$0.05 in the year-ago quarter.

The reported revenue represents a surprise of +1.56% over the Zacks Consensus Estimate of $1.22 billion. With the consensus EPS estimate being $0.01, the EPS surprise was +400%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Alignment Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Medical benefits ratio: 88.2% versus the five-analyst average estimate of 88.3%.
  • Health Plan Membership - Ending: 284,800 versus the four-analyst average estimate of 283,153.
  • Revenues- Other: $8.63 million compared to the $9.66 million average estimate based on three analysts. The reported number represents a change of -2.9% year over year.
  • Revenues- Earned premiums: $1.23 billion versus the three-analyst average estimate of $1.21 billion. The reported number represents a year-over-year change of +33.6%.

View all Key Company Metrics for Alignment Healthcare here>>>

Shares of Alignment Healthcare have returned +21.7% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in